- Report
- March 2024
- 146 Pages
Global
From €3755EUR$3,899USD£3,229GBP
- Report
- July 2023
- 510 Pages
Global
From €1916EUR$1,990USD£1,648GBP
- Report
- February 2024
- 182 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- November 2023
- 190 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- February 2024
- 120 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- June 2023
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- November 2023
- 182 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- October 2023
- 174 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- September 2023
- 210 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- August 2023
- 150 Pages
Global
From €4093EUR$4,250USD£3,520GBP
- Report
- September 2023
- 205 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
From €7656EUR$7,950USD£6,584GBP
From €5730EUR$5,950USD£4,928GBP
From €6260EUR$6,500USD£5,383GBP
- Report
- February 2024
- 105 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 236 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 90 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 118 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 90 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 120 Pages
Global
From €4574EUR$4,750USD£3,934GBP
The Type 2 diabetes market, within the context of diabetes devices, encompasses a range of products designed to monitor and control blood glucose levels, as well as deliver insulin for patients in need of external sources of the hormone. Key devices include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These devices are essential for patients to manage their condition effectively, helping to reduce the risk of complications associated with diabetes and improving overall quality of life. Advances in technology have led to the development of more accurate, user-friendly, and integrated devices, many of which can connect to smartphone apps and health management platforms to assist in tracking and analyzing diabetic data over time. This integration facilitates better personalized care and more refined treatment plans.
Companies active in the Type 2 diabetes devices market comprise a mix of established pharmaceutical companies and specialized medical device manufacturers. Some notable companies include Medtronic, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, LifeScan, Inc., and Roche Diabetes Care. These companies are at the forefront of innovation in the diabetes devices sector, investing in research and development to offer advanced solutions that address the needs of those managing Type 2 diabetes. Show Less Read more